Acquisition - July 3, 2015
Novo to End Tresiba in Germany
Novo Nordisk will stop distribution of its once-daily insulin drug Tresiba after price negotiations with Germany’s health insurance fund trade group broke down, according to BioSpace.com. Company officials indicated they could not come to an agreement on price with GKV-Spitzenverband, which wanted to set the price level equal to that of human insulin. The company […]
Acquisition - July 1, 2015
InDex, Almirall S.A End Agreement
InDex Pharmaceuticals terminated a license agreement with Almirall S.A. involving the drug candidate Kappaproct® for the treatment of ulcerative colitis. The agreement had given Almirall licensed exclusive rights to Kappaproct® for the European market. Now InDex regains all worldwide development and commercialization rights for Kappaproct®, which is in late-stage clinical development. “With global rights to […]
Acquisition - June 5, 2015
Cortendo Buys Endocrine Disease Treatments
Swedish-American biotech company Cortendo is buying a pair of Phase II treatments for acromegaly for a total of $35 million, according to FierceBiotech. Cortendo agreed to pay Aspireo Pharmaceuticals $30 million for somatoprim, or DG3173, a treatment designed to block the excess growth hormone production that characterizes acromegaly. The drug showed positive results on hormone […]
Acquisition - June 3, 2015
SymCel Device Hits Markets
SymCel’s calScreener™ technology is going in nine locations across five different countries in a mixture of university institutions and pharmaceutical companies. The nine include four signings in Sweden, two signings in Switzerland, and one each in Holland, South Africa, Germany and South East Asia Scientific data published in The Biotechnology Journal shows that CalScreener’s isothermal microcalorimetry label free […]
Acquisition - May 29, 2015
Olympian Promoting OIC Awareness
AstraZeneca and Daiichi Sankyo have partnered with six-time Olympic medalist Jackie Joyner-Kersee to increase awareness of opioid-induced constipation (OIC). Joyner-Kersee speaks candidly about her struggle with OIC after taking opioid medication prescribed by her healthcare provider to help manage pain stemming from years of training to compete in the long jump and heptathlon. She earned […]
Acquisition - May 18, 2015
Bavarian Nordic Gets Loan
Bavarian Nordic has secured a loan facility of EUR 50 million from the European Investment Bank (EIB). The loan facility has been issued to support the research and development of vaccines against Ebola and other infectious diseases as well as cancer immunotherapies, according to BioSpace.com. The loan facility provides Bavarian Nordic a chance to speed […]
